Samchundang Pharm to induce nifedipine sustained-release formulation technology

Published: 2004-04-09 06:56:00
Updated: 2004-04-09 06:56:00
Samchundang Pharm said on April 6 that it will induce nifedipine sustained-release formulation technology under a contract with the Korea Research Institute of Chemical and Technology.

Under the contract, Samchundang is to pay the KRICT 100 milllion won in down payments plus running royalty co...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.